GlassScriptPhysician profile
Amber M Ervin
NPI 1811139371
$1,130.85
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38.19 · 2020: $14.59 · 2021: $77.56 · 2022: $468 · 2023: $397 · 2024: $135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $532.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $532.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $155.29 | 2021-2023 | |
| Idorsia Pharmaceuticals US INC | $150.83 | 2022-2024 | Quviviq |
| Astrazeneca Pharmaceuticals LP | $141.51 | 2022-2024 | Farxiga, Breztri |
| Pfizer INC. | $100.22 | 2022-2023 | |
| Novo Nordisk INC | $81.15 | 2022-2024 | Rybelsus, Ozempic, Wegovy |
| Novartis Pharmaceuticals Corporation | $60.50 | 2022-2024 | |
| Mylan Specialty L.P. | $52.99 | 2023-2024 | Yupelri |
| Janssen Pharmaceuticals, INC | $52.78 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $51.20 | 2022-2023 | Jardiance |
| Lilly USA, LLC | $51.12 | 2022-2023 | Mounjaro |
| Radius Health, INC. | $46.23 | 2023-2024 | Tymlos |
| Bayer Healthcare Pharmaceuticals INC. | $27.51 | 2022-2023 | |
| Antares Pharma, INC. | $25.74 | 2022 | |
| Merck Sharp & Dohme LLC | $25.31 | 2022 | |
| Amgen INC. | $23.31 | 2024 | Krystexxa |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $21.94 | 2022 | |
| Horizon Therapeutics Plc | $18.30 | 2022 | |
| Insulet Corporation | $17.08 | 2023 | Omnipod |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.67 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $13.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Ervin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.